| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.22 | 7e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |